SBI Nifty100 Low Volatility 30 Index Fund
The scheme seeks to provide returns that correspond to the total returns of the securities as represented by the underlying index, subject to tracking error.
Growthvine rating: 2/5 — ranked #31 of 42 in category.
Fund basics
| Category | Equity: Large Cap |
|---|
| NAV | ₹9.38 (as of 2026-10-23) |
|---|
| AUM | ₹52 Cr |
|---|
| Expense ratio | 0.67% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Viral Chhadva |
|---|
| Exit load | 0.25% for redemption within 15 days |
|---|
Performance & risk
| Standard deviation | 0.00% |
|---|
| Max drawdown | −14.37% |
|---|
| Alpha | 0 |
|---|
| Beta | 0 |
|---|
Over 5 years, captured 85.9% of NIFTY 100's upside and 90.9% of its downside.
Market cap allocation
| Large cap | 96.8% |
|---|
| Mid cap | 3.2% |
|---|
| Small cap | 0.0% |
|---|
Concentration
| Top 5 holdings | 18.9% |
|---|
| Top 10 holdings | 36.9% |
|---|
| Total holdings | 30 |
|---|
| Index overlap | 43.1% |
|---|
| Active share | 56.9% |
|---|
Top holdings
- ICICI Bank Ltd. — 3.8%
- Sun Pharmaceutical Industries Ltd. — 3.8%
- Apollo Hospitals Enterprises Ltd. — 3.8%
- NTPC Limited — 3.8%
- Britannia Industries Ltd. — 3.7%
- Bharti Airtel Ltd. — 3.7%
- Kotak Mahindra Bank Ltd. — 3.6%
- SBI Life Insurance Company Limited — 3.6%
- Nestle India Ltd. — 3.5%
- ITC Ltd — 3.5%
Top sectors
- Banking & Financial — 13.9%
- Pharma & Biotech — 13.8%
- Miscellaneous — 13.8%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | −11.9% | Q4 (Bottom) | #34 of 39 |